These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15101124

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Focus on ziprasidone.
    Green B.
    Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
    Mendelowitz AJ.
    Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients.
    Sagud M, Nikolac M, Mihaljevic-Peles A, Nedic G, Vuksan Cusa B, Mustapic M, Jakovljevic M, Muck-Seler D, Pivac N.
    Psychopharmacology (Berl); 2012 Feb; 219(4):1179-81. PubMed ID: 21989808
    [No Abstract] [Full Text] [Related]

  • 7. Med-psych drug-drug interactions update.
    Armstrong SC, Cozza KL.
    Psychosomatics; 2001 Feb; 42(5):435-7. PubMed ID: 11739913
    [No Abstract] [Full Text] [Related]

  • 8. Tolerability of ziprasidone: an expanding perspective.
    Daniel DG.
    J Clin Psychiatry; 2003 Feb; 64 Suppl 19():40-9. PubMed ID: 14728089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
    Gunasekara NS, Spencer CM, Keating GM.
    Drugs; 2002 Feb; 62(8):1217-51. PubMed ID: 12010089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Parkinsonism with intramuscular ziprasidone.
    Bilal L, Tsai C, Gasper JJ, Ndlela JC.
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract] [Full Text] [Related]

  • 13. [The new antipsychotic preparation Rispolept (risperidone)].
    Iakovlev VA.
    Voen Med Zh; 1999 Nov; 320(11):43-5. PubMed ID: 10650767
    [No Abstract] [Full Text] [Related]

  • 14. Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.
    Stip E, Zhornitsky S, Moteshafi H, Létourneau G, Stikarovska I, Potvin S, Tourjman V.
    Clin Ther; 2011 Dec; 33(12):1853-67. PubMed ID: 22133697
    [Abstract] [Full Text] [Related]

  • 15. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
    Rossi A, Cañas F, Fagiolini A, Larmo I, Levy P, Montes JM, Papageorgiou G, Sturlason R, Zink M, Correll CU.
    Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
    [Abstract] [Full Text] [Related]

  • 16. From clinical research to clinical practice: a 4-year review of ziprasidone.
    Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, Kilts CD, Daniel DG.
    CNS Spectr; 2005 Nov; 10(11 Suppl 17):1-20. PubMed ID: 16381088
    [Abstract] [Full Text] [Related]

  • 17. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
    Kinzie E, Meltzer-Brody S.
    Gen Hosp Psychiatry; 2005 Nov; 27(3):223-4. PubMed ID: 15882772
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM.
    J Clin Psychiatry; 2003 Nov; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic Malignant Syndrome with ziprasidone.
    Murty RG, Mistry SG, Chacko RC.
    J Clin Psychopharmacol; 2002 Dec; 22(6):624-6. PubMed ID: 12454565
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.